iifl-logo-icon 1

Biogen Pharmachem Industries Ltd Share Price

1.23
(9.82%)
Jul 3, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open1.13
  • Day's High1.31
  • 52 Wk High1.85
  • Prev. Close1.12
  • Day's Low1.12
  • 52 Wk Low0.68
  • Turnover (lac)344.59
  • P/E41
  • Face Value1
  • Book Value0.86
  • EPS0.03
  • Mkt. Cap (Cr.)80.27
  • Div. Yield0
No Records Found

Biogen Pharmachem Industries Ltd KEY RATIOS

Sector

Finance

CMP
as on 03 Jul, 2024 12:00:00 AM

1.23 -9.82 -0.11

Open

1.13

Prev. Close

1.12

Turnover(Lac.)

344.59

Day's High

1.31

Day's Low

1.12

52 Week's High

1.85

52 Week's Low

0.68

Book Value

0.86

Face Value

1

Mkt Cap (₹ Cr.)

80.27

P/E

41

EPS

0.03

Divi. Yield

0

Biogen Pharmachem Industries Ltd Corporate Action

10 Jan 2024

12:00 AM

EGM

arrow

21 Sep 2023

12:00 AM

AGM

Announcement Date: 21 Sep, 2023

arrow

10 Jan 2024

12:00 AM

BookCloser

arrow

16 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Biogen Pharmachem Industries Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Biogen Pharmachem Industries Ltd SHAREHOLDING SNAPSHOT

03 Jul, 2024|12:01 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 0.00%

Foreign: 0.00%

Indian: 0.00%

Non-Promoter- 0.01%

Institutions: 0.00%

Non-Institutions: 99.99%

Custodian: 0.00%

Share Price

Biogen Pharmachem Industries Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

65.26

65.26

65.26

65.26

Preference Capital

0

0

0

0

Reserves

-10.67

-11.13

-11.12

-9.51

Net Worth

54.59

54.13

54.14

55.75

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2016Mar-2015Mar-2014Mar-2013

Revenue

0

0

0

0

yoy growth (%)

0

0

0

0

Raw materials

0

0

0

0

As % of sales

0

0

0

0

Employee costs

0

0

0

0

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2016Mar-2015Mar-2014Mar-2013

Profit before tax

0

0

0

0

Depreciation

0

0

0

0

Tax paid

0

0

0

0

Working capital

-4.69

5.77

1.2

-22.35

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2016Mar-2015Mar-2014Mar-2013

Growth matrix (%)

Revenue growth

0

0

0

0

Op profit growth

0

0

0

0

EBIT growth

0

0

0

0

Net profit growth

0

0

0

0

View Ratios

No Record found

Biogen Pharmachem Industries Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Bajaj Finance Ltd

BAJFINANCE

7,186.25

35.044,43,359.213,401.910.512,486.591,158.54

Bajaj Finserv Ltd

BAJAJFINSV

1,587.25

215.542,52,256.647.820.0643.6341.14

Indian Railway Finance Corporation Ltd

IRFC

172.85

35.022,24,712.961,717.320.876,473.5637.63

Jio Financial Services Ltd

JIOFIN

352.55

02,23,000.2877.760140.5138.46

Power Finance Corporation Ltd

PFC

526.3

11.541,65,813.614,135.452.6912,243.69240

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Biogen Pharmachem Industries Ltd

Management

Register Office

Registrar Office

Chairman & WTD & CFO

Niraj Vaghela

Independent Director

Chandrakant Govingbhai Parmar

Company Sec. & Compli. Officer

Khushboo Khandelwal

Director

Harshadkumar Rathod

Director

Narendrakumar Vaniya

Director

Komalben Chauhan

Non Executive Director

CHHAYA PARMAR

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Biogen Pharmachem Industries Ltd was formerly incorporated as Wellworth Overseas Limited in July, 1995. The name of the Company was changed to Sun Techno Overseas Limited in August 2011 and again the name got changed from Sun Techno Overseas Limited to Biogen Pharmachem Industries Limited on March 24,2021. The Company is engaged in the business of trading in shares and securities in present and future market. It trades in commodities, including agro based and precious metals, and other goods. The company also provides stock broking and consulting services. In addition, it generates, trades, and sells wind power. As of March 31, 2009, the Company had started trading operations and business in commodities, both in agro-based and precious metals, and other goods in present and future markets. During the fiscal year ended March 31, 2009 (fiscal 2009), the Company was exploring opportinuities to do the business of import, export and trading in gold, silver and other precious metals, including diamond. The Company is also diversifying its business activities in the power sector, by establishing wind power generation plant.Company has changed its main objects to Pharmaceutical company dated 8th March 2021.
Read More

Company FAQs

What is the Biogen Pharmachem Industries Ltd share price today?

Down Arrow

The Biogen Pharmachem Industries Ltd shares price on nse is Rs.₹1.23 today.

What is the Market Cap of Biogen Pharmachem Industries Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Biogen Pharmachem Industries Ltd is ₹80.27 Cr. as of 03 Jul ‘24

What is the PE and PB ratio of Biogen Pharmachem Industries Ltd?

Down Arrow

The PE and PB ratios of Biogen Pharmachem Industries Ltd is 41 and 1.42 as of 03 Jul ‘24

What is the 52 Week High and Low of Biogen Pharmachem Industries Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Biogen Pharmachem Industries Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Biogen Pharmachem Industries Ltd is ₹0.68 and ₹1.85 as of 03 Jul ‘24

What is the CAGR of Biogen Pharmachem Industries Ltd?

Down Arrow

Biogen Pharmachem Industries Ltd's CAGR for 5 Years at 42.59%, 3 Years at 30.84%, 1 Year at 13.13%, 6 Month at -18.25%, 3 Month at 0.00% and 1 Month at -2.61%.

What is the shareholding pattern of Biogen Pharmachem Industries Ltd?

Down Arrow

The shareholding pattern of Biogen Pharmachem Industries Ltd is as follows:
Promoters - 0.00 %
Institutions - 0.00 %
Public - 100.00 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.